Latest data from June 17, 2022
Number of Health Center respondents = 50 (79% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 17,189 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 78.84% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 1,701 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 80.94% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 15.42% | 14.52% |
| White, Hispanic/Latino Patients | 7.64% | 9.17% |
| Black/African American, Non-Hispanic/Latino Patients | 19.34% | 16.34% |
| Black/African American, Hispanic/Latino Patients | 1.87% | 1.59% |
| Asian Patients3 | 6.92% | 8.52% |
| American Indian/Alaska Native Patients3 | 0.91% | 1.94% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.58% | 0.59% |
| Patients with More Than One Race3 | 1.85% | 2.29% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 18.35% | 21.22% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.47% | 7.88% |
| Unreported/Refused to Report Race and Ethnicity | 20.65% | 15.93% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,611 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 89.92% |
| COVID-19 Immunization Series Completed | 1,600 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 86.77% |
| COVID-19 Immunization Series Additional | 5,151 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 83.67% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 8.44% | 11.56% | 14.25% |
| White, Hispanic/Latino Patients | 11.86% | 6.38% | 9.01% |
| Black/African American, Non-Hispanic/Latino Patients | 34.89% | 34.62% | 23.61% |
| Black/African American, Hispanic/Latino Patients | 2.61% | 4.19% | 1.86% |
| Asian Patients3 | 3.66% | 5.56% | 11.47% |
| American Indian/Alaska Native Patients3 | 0.81% | 0.50% | 4.39% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.87% | 0.75% | 0.31% |
| Patients with More Than One Race3 | 3.85% | 4.62% | 2.93% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 16.76% | 19.19% | 19.41% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.03% | 3.88% | 4.08% |
| Unreported/Refused to Report Race and Ethnicity | 11.24% | 8.75% | 8.68% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 16.00% |
| 1 to 24 Hours | 30.00% |
| More Than 24 Hours | 52.00% |
| N/A | 2.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 12.00% |
| Staffing to administer the vaccine | 20.00% |
| Vaccine confidence | 38.00% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 8.00% |
| None | 44.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 30.00% |
| Average Percent of Health Center Visits Conducted Virtually | 14.40% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 26.00% |
| Number of Mobile Van Sites | 13 |
| Number of Pop-up Clinics | 80 |
| Number of School-Based Vaccination Sites | 1 |
| Number of Family Vaccination Clinics | 16 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 6.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 54.00% |
| None | 42.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 4.00% |
| Patient awareness/education | 4.00% |
| Staffing capacity | 16.00% |
| Therapy administration/onsite logistics | 22.00% |
| Other | 2.00% |
| None | 58.00% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 31 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 15,275 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 87.10% |
| Provided to General Public Who Came to the Health Center | 48.39% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 22.58% |
| Provided at Other Community Events | 29.03% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 9.68% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 22.58% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 19.35% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 19.35% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 19.35% |
| Other | 16.13% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 21 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 18,841 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 85.71% |
| Provided to General Public Who Came to the Health Center | 42.86% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 33.33% |
| Provided at Other Community Events | 38.10% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 19.05% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 38.10% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 28.57% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 28.57% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 19.05% |
| Other | 9.52% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 14 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 54.74% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 36.84% |
| White, Hispanic/Latino Patients | 12.63% |
| Black/African American, Non-Hispanic/Latino Patients | 11.05% |
| Black/African American, Hispanic/Latino Patients | 2.11% |
| Asian Patients3 | 7.37% |
| American Indian/Alaska Native Patients3 | 0.53% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.53% |
| Patients with More Than One Race3 | 1.58% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 18.95% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.74% |
| Unreported/Refused to Report Race and Ethnicity | 3.68% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 0.53% |
| Patients Who Are Residents of Public Housing | 34.21% |
| Patients with Limited English Proficiency | 21.58% |
| Children Under 18 Years of Age | 0.53% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: